Women Surviving Ovarian Cancer
NCT00596349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2009-02-26
Summary
The purpose of this study is to help us learn more about how women who have had or now have ovarian cancer are doing 5 years or more from their diagnosis. We want to learn about general quality of life, long-term side effects of treatment, sexual function, thinking, memory, and psychological effects (such as anxiety and depression). We will also look at how these women are being followed for ovarian cancer. We hope this study will help us better understand how women surviving ovarian cancer are doing.
Conditions
- Epithelial Ovarian Cancer
- Quality of Life
- Survivorship
Interventions
- BEHAVIORAL
-
questionnaires
study participants complete one-time survey, questionnaires, and cognition testing, comprising the following: QOL-Cancer Survivor FACT-Ovarian SF-36 (general QOL scale) CES-D (depression scale) Impact of Events Scale (anxiety scale) FACT-GOG-NTX (neurotoxicity scale) Female Sexual Functioning Index (FSFI) Cognition Testing Perception of disease chronicity/acuity Concerns about Recurrence Report of surveillance type, frequency, utility Health behaviors Self-report of co-morbidities Self-report of potential unmet needs Background information form List of current medications Patient-defined QoL domains
- BEHAVIORAL
-
questionnaires
study participants complete one-time survey, questionnaires, and cognition testing, comprising the following: QOL-Cancer Survivor FACT-Ovarian SF-36 (general QOL scale) CES-D (depression scale) Impact of Events Scale (anxiety scale) FACT-GOG-NTX (neurotoxicity scale) Female Sexual Functioning Index (FSFI) Cognition Testing Perception of disease chronicity/acuity Concerns about Recurrence Report of surveillance type, frequency, utility Health behaviors Self-report of co-morbidities Self-report of potential unmet needs Background information form List of current medications Patient-defined QoL domains
- BEHAVIORAL
-
questionnaires
study participants complete one-time survey, questionnaires, and cognition testing, comprising the following: QOL- Cancer Survivor, FACT-Ovarian, SF-36, CES-D, IES, FACT-GOG-NTX, FSFI, Cognition Testing, Perception of disease chronicity/acuity, Report of surveillance type, frequency, utility, Health behaviors, Self-report of co-morbidities, Self-report of potential unmet needs, Background information form, List of current medications,Patient-defined QoL domains
Sponsors & Collaborators
-
Queens Cancer Center of Queens Hospital
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NCT06312124 ·Status: RECRUITING ·Phase: NA
-
DOD Long-Term Survivors of Ovarian Cancer
NCT02321735 ·Status: UNKNOWN ·Phase: NA
-
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
NCT05752448 ·Status: RECRUITING ·Phase: NA
-
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
NCT02082470 ·Status: COMPLETED ·Phase: NA
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00958698 ·Status: UNKNOWN ·Phase: NA
-
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
NCT01080521 ·Status: COMPLETED
-
The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
NCT02569983 ·Status: COMPLETED
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 ·Status: NOT_YET_RECRUITING
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT00003772 ·Status: COMPLETED
-
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT01372787 ·Status: UNKNOWN
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Advanced Ovarian Cancer and Sexuality Phase 1
NCT00488202 ·Status: COMPLETED
-
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer
NCT00004909 ·Status: COMPLETED
-
Why do Oral Contraceptives Prevent Ovarian Cancer?
NCT02155777 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Long Term Survivors in Ovarian Cancer
NCT03128294 ·Status: TERMINATED
-
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
NCT00039559 ·Status: UNKNOWN ·Phase: NA
-
The Longitudinal Ovarian Reserve Study
NCT02395341 ·Status: COMPLETED
-
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
NCT03956095 ·Status: COMPLETED
-
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
NCT00445887 ·Status: COMPLETED ·Phase: PHASE2